News
Smartphone-based home screening significantly boosts chronic kidney disease (CKD) diagnosis and follow-up care, enhancing ...
Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.
With CT scans picking up more cases of sclerosing mesenteritis, be prepared to diagnose this poorly understood autoimmune ...
Altimmune’s pemvidutide failed to significantly improve fibrosis in MASH patients in a Phase IIb study. The biotech crashed ...
The site was created by Boehringer Ingelheim after a survey identified knowledge gaps among owners on many health topics ...
A Fierce Pharma Marketing review of the LinkedIn and Instagram pages of the 20 largest pharmas found that, as of Thursday, ...
Empagliflozin has kidney protective effects and reduces heart failure outcomes across baseline kidney function among patients ...
Some women may be unaware they’re living with risks for heart disease, kidney disease and metabolic conditions like diabetes, ...
For high-risk patients with type 2 diabetes, oral semaglutide reduced risk for major cardiovascular and ischemic limb-related ...
Altimmune’s GLP-1/glucagon dual receptor agonist achieved a hit and a miss when it came to the dual goals of a phase 2 ...
The Animal Health Institute named Gene Harrington senior director of state affairs. Bob Ellison joined Agri-Pulse as managing ...
While its heirs rank among the world’s youngest billionaires, the German drugmaker Boehringer Ingelheim is rather ancient—it was founded in 1885, and its entrepreneurial roots stretch back ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results